CSPC Pharmaceutical Group Ltd. logo

CSPC Pharmaceutical Group Ltd. (CSPCY)

Market Closed
11 Jul, 20:00
OTC PINK OTC PINK
$
3. 95
-0.17
-4.13%
$
11.81B Market Cap
11.41 P/E Ratio
0.23% Div Yield
3,600 Volume
0 Eps
$ 4.12
Previous Close
Day Range
3.95 4
Year Range
2.15 4.62
Want to track CSPCY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CSPCY closed yesterday lower at $3.95, a decrease of 4.13% from Thursday's close, completing a monthly increase of 0.25% or $0.01. Over the past 12 months, CSPCY stock gained 68.09%.
CSPCY pays dividends to its shareholders, with the most recent payment made on Dec 05, 2024. The next announced payment will be in In 2 weeks on Aug 01, 2025 for a total of $0.05142.
The last earnings report, released on May 26, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
CSPC Pharmaceutical Group Ltd. has completed 2 stock splits, with the recent split occurring on Nov 16, 2020.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

CSPCY Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.

CSPC Pharmaceutical Group Ltd. Dividends

CSPC Pharmaceutical Group Ltd. logo
CSPCY 1 month ago
Announced
Other
$0.05 Per Share
CSPC Pharmaceutical Group Ltd. logo
CSPCY 8 months ago
Paid
Other
$0.08 Per Share
CSPC Pharmaceutical Group Ltd. logo
CSPCY 3 Jun 2024
Paid
Other
$0.07 Per Share
CSPC Pharmaceutical Group Ltd. logo
CSPCY 7 Sep 2023
Paid
Other
$0.07 Per Share
CSPC Pharmaceutical Group Ltd. logo
CSPCY 5 Jun 2023
Paid
Other
$0.06 Per Share

CSPC Pharmaceutical Group Ltd. Earnings

26 May 2025 Date
-
Cons. EPS
-
EPS
18 Mar 2025 Date
-
Cons. EPS
-
EPS
28 Nov 2024 Date
-
Cons. EPS
-
EPS
21 Aug 2024 Date
-
Cons. EPS
-
EPS
27 May 2024 Date
-
Cons. EPS
-
EPS
CSPC Pharmaceutical Group Ltd. logo
CSPCY 1 month ago
Announced
Other
$0.05 Per Share
CSPC Pharmaceutical Group Ltd. logo
CSPCY 8 months ago
Paid
Other
$0.08 Per Share
CSPC Pharmaceutical Group Ltd. logo
CSPCY 3 Jun 2024
Paid
Other
$0.07 Per Share
CSPC Pharmaceutical Group Ltd. logo
CSPCY 7 Sep 2023
Paid
Other
$0.07 Per Share
CSPC Pharmaceutical Group Ltd. logo
CSPCY 5 Jun 2023
Paid
Other
$0.06 Per Share
26 May 2025 Date
-
Cons. EPS
-
EPS
18 Mar 2025 Date
-
Cons. EPS
-
EPS
28 Nov 2024 Date
-
Cons. EPS
-
EPS
21 Aug 2024 Date
-
Cons. EPS
-
EPS
27 May 2024 Date
-
Cons. EPS
-
EPS

CSPC Pharmaceutical Group Ltd. (CSPCY) FAQ

What is the stock price today?

The current price is $3.95.

On which exchange is it traded?

CSPC Pharmaceutical Group Ltd. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is CSPCY.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.23%.

What is its market cap?

As of today, the market cap is 11.81B.

Has CSPC Pharmaceutical Group Ltd. ever had a stock split?

CSPC Pharmaceutical Group Ltd. had 2 splits and the recent split was on Nov 16, 2020.

CSPC Pharmaceutical Group Ltd. Profile

Drug Manufacturers - General Industry
Healthcare Sector
Mr. Cuilong Zhang CEO
OTC PINK Exchange
12591J207 Cusip
CN Country
21,400 Employees
5 Jun 2025 Last Dividend
16 Nov 2020 Last Split
- IPO Date

Overview

CSPC Pharmaceutical Group Limited, established in 1992 and headquartered in Shijiazhuang, the People's Republic of China, is a prominent investment holding company specializing in the pharmaceutical sector. The company stands out for its comprehensive involvement in researching, developing, manufacturing, and distributing pharmaceutical products across a wide geographical stretch that includes the People's Republic of China, other Asian regions, North America, Europe, and beyond in the global market. Operating through its strategic divisions—Finished Drugs, Bulk Products, and Functional Food and Others—CSPC Pharmaceutical has cemented its reputation as a leading provider of a variety of pharmaceutical solutions. A significant milestone in the company's history is its strategic partnership with Pfizer Inc., aimed at launching a local brand of the COVID-19 oral therapeutic treatment Nirmatrelvir/Ritonavir in China, showcasing its commitment to contributing to global health crises solutions. Originally known as China Pharmaceutical Group Limited, the company rebranded to CSPC Pharmaceutical Group Limited in March 2013 to better reflect its expansive scope and ambitions.

Products and Services

  • NBP soft capsules and injections: Designed for the treatment of acute ischemic stroke, offering crucial intervention in the early stages of stroke management.
  • Oulaining capsules and injections: Prescribed for mild to moderate memory and mental impairment, enhancing cognitive functions in affected individuals.
  • Enxi: A medication aimed at treating adult idiopathic Parkinson's disease, offering relief and improving the quality of life for patients.
  • Duomeisu: Focused on the treatment of lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors, showcasing the company's dedication to cancer care.
  • Jinyouli: Developed to prevent leucopenia and infection induced by chemotherapy, supporting patients through their cancer treatment process.
  • Keaili: Another of the company’s oncology offerings, specifically targeting breast cancer treatment.
  • Antibiotics, Vitamin C, and Caffeine APIs: Critical components in the development of a range of pharmaceutical applications, highlighting CSPC's diverse approach to health solutions.
  • Functional food and glucose products: Expanding beyond pharmaceuticals, these offerings cater to the broader health and wellness sector, providing nutritional and health maintenance options.
  • Healthcare services: Beyond products, CSPC offers a spectrum of healthcare services, reinforcing its comprehensive approach towards healthcare provision and patient support.

Contact Information

Address: No. 226 Huanghe Street
Phone: 86 31 1870 37015